Protagonist Therapeutics PTGX Total Liabilities & Equity
Total Liabilities & Equity at other companies
Other financials
Where this comes from
Reported directly by Protagonist Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.
The official record: Protagonist Therapeutics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Protagonist Therapeutics's total liabilities & equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Protagonist Therapeutics's total liabilities & equity?
- Protagonist Therapeutics (PTGX) reported total liabilities & equity of $697.46M in Q1 2026.
- How has Protagonist Therapeutics's total liabilities & equity changed year-over-year?
- Protagonist Therapeutics's total liabilities & equity decreased by 6.0% year-over-year, from $742.13M to $697.46M.
- What is the long-term trend for Protagonist Therapeutics's total liabilities & equity?
- Over 5 years (2020 to 2025), Protagonist Therapeutics's total liabilities & equity has grown at a 15.5% compound annual growth rate (CAGR), from $324.47M to $668.19M.
- What does total liabilities & equity mean?
- Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.